| Literature DB >> 15604363 |
Atsunori Fukuhara1, Morihiro Matsuda, Masako Nishizawa, Katsumori Segawa, Masaki Tanaka, Kae Kishimoto, Yasushi Matsuki, Mirei Murakami, Tomoko Ichisaka, Hiroko Murakami, Eijiro Watanabe, Toshiyuki Takagi, Megumi Akiyoshi, Tsuguteru Ohtsubo, Shinji Kihara, Shizuya Yamashita, Makoto Makishima, Tohru Funahashi, Shinya Yamanaka, Ryuji Hiramatsu, Yuji Matsuzawa, Iichiro Shimomura.
Abstract
Fat tissue produces a variety of secreted proteins (adipocytokines) with important roles in metabolism. We isolated a newly identified adipocytokine, visfatin, that is highly enriched in the visceral fat of both humans and mice and whose expression level in plasma increases during the development of obesity. Visfatin corresponds to a protein identified previously as pre-B cell colony-enhancing factor (PBEF), a 52-kilodalton cytokine expressed in lymphocytes. Visfatin exerted insulin-mimetic effects in cultured cells and lowered plasma glucose levels in mice. Mice heterozygous for a targeted mutation in the visfatin gene had modestly higher levels of plasma glucose relative to wild-type littermates. Surprisingly, visfatin binds to and activates the insulin receptor. Further study of visfatin's physiological role may lead to new insights into glucose homeostasis and/or new therapies for metabolic disorders such as diabetes.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15604363 DOI: 10.1126/science.1097243
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728